Chat with us, powered by LiveChat

Post Operative Nausea and Vomiting Market (Treatment Type - Serotonin Antagonists, Dopamine Antagonists, NK-1 Receptor Antagonists, and Non-pharmacological Treatment; Distribution Channel - Hospital Pharmacies, and Retail Pharmacies & Drug Stores): Global Industry Analysis, Trends, Size, Share and Forecasts to 2028

Post Operative Nausea and Vomiting Market (Treatment Type - Serotonin Antagonists, Dopamine Antagonists, NK-1 Receptor Antagonists, and Non-pharmacological Treatment; Distribution Channel - Hospital Pharmacies, and Retail Pharmacies & Drug Stores): Global Industry Analysis, Trends, Size, Share and Forecasts to 2028

Report Code: HC08708 Category: Healthcare & Medical Devices Published: August, 2022

A recent report published by Infinium Global Research on post operative nausea and vomiting market provides an in-depth analysis of segments and sub-segments in the global as well as regional post operative nausea and vomiting market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional post operative nausea and vomiting market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global post operative nausea and vomiting market. According to the report, the global post operative nausea and vomiting market is projected to grow at a CAGR of over 8% over the forecast period of 2022-2028.

 

Market Insight

The global post operative nausea and vomiting market size to grow from about USD 2200 million in 2022 to nearly USD 3600 million by 2028, at a CAGR of over 8% during the forecast period. Post operative nausea and vomiting are uncomfortable for patients and can lead to more serious complications. It is an enormous problem for patients recovering after surgery. About 30% of people experience vomiting and 50% experience nausea. As many as 80% of high-risk individuals may experience post operative nausea and vomiting.

 


Post Operative Nausea and Vomiting Market


Post operative nausea and vomiting (PONV) are amongst the most frequently occurring complications in patients undergoing surgery with general anesthesia. Nausea and vomiting are common and distressing symptoms or side effects in medicine, surgery, and following anesthesia. Generally, uncomplicated PONV rarely goes beyond 24 hours post operatively and problematic PONV however is more multifactorial in origin and can be difficult to treat effectively. Patients at risk of this should be identified by the anesthetist and may be given prophylactic anti-emetic treatment. Post operative nausea and vomiting (PONV) are one of the complex and significant problems in anesthesia practice, with the growing trend toward ambulatory and daycare surgeries. A growing adoption rate of combination therapies as well as non-pharmacological treatment modes is driving the growth of the market. Moreover, the surge in funding is expected to boost the growth of post operative nausea and vomiting (PONV) market during the forecast period. However, strict regulatory approvals and high health care expenditure is affecting the growth of the market during the forecast period. Moreover, the launch of newer therapies is anticipated to provide a significant growth opportunity for the market.

 

Nausea and vomiting (PONV) are frequent after general anesthesia and enhance the risk of infection to health professionals and patient discomfort. The Medication for PONV treatment may present adverse effects on patients with COVID-19. Antiemetics have gained an active position in the COVID-19 pandemic as a medical approach to suppressing SARS-CoV-2-induced nausea and vomiting and balancing side effects from medications in use. Additionally, these antiemetics may even be more important in the field of emergency surgical patients with COVID-19 who might be treated more likely with open surgery and therefore more prone to nausea and vomiting.

 

North America holds the largest market share in the post operative nausea and vomiting (PONV) market. Healthcare remuneration in the United States of America (USA) has transitioned from volume-based systems to value-based systems. This means healthcare institutions are financially incentivized to provide care according to evidence-based best practices. Furthermore, a large presence of local pharmaceutical companies in this region is expected to propel market growth in the North American region. Moreover, Asia Pacific is expected to grow with a healthy CAGR. A growing number of patients undergoing surgical procedures and an increase in compliance with pharmacologic and non-pharmacologic treatments are attributing to the growth of the market in this region.

 

Segment Covered

The report on the global post operative nausea and vomiting market covers segments such as treatment type, and distribution channel. On the basis of treatment type, the sub-markets include serotonin antagonists, dopamine antagonists, NK-1 receptor antagonists, and non-pharmacological treatment. On the basis of distribution channel, the sub-markets include hospital pharmacies, and retail pharmacies & drug stores.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Novartis AG, Acacia Pharma, Hoffmann-La Roche AG, Camurus AB, Sanofi S.A, Helsinn Holding S.A, Eisai Corporation, Merck and Co, and GlaxoSmithKline Corporation.

 

Report Highlights:

The report provides deep insights into demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of post operative nausea and vomiting market. Moreover, the study highlights current market trends and provides forecast from 2022-2028. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings insight into the market share of the leading players.


CHOOSE LICENCE TYPE

Please Choose One of them.

© 2024. Infinium Global Research LLP. All Rights Reserved.